Related Experiment Videos
Cross-validation for linear model with unequal variances in genomic analysis.
Li Li1, Shein-Chung Chow, Woollcott Smith
1Clinical Discovery Department, Bristol-Myers Squibb, Princeton, New Jersey 08543-4000, USA. lili@bms.com
Journal of Biopharmaceutical Statistics
|October 8, 2004
Summary
This study extends a linear model selection method for genomic studies to handle unequal variances. New re-sampling techniques improve predictive model validation in clinical development.
Area of Science:
- Genomics
- Biostatistics
- Clinical Trials
Background:
- Genomic studies identify genes for predictive models in clinical trials.
- Predictive models aid treatment response identification but require validation.
- Existing methods like Shao's (1993) assume equal variances, limiting applicability.
Purpose of the Study:
- To extend Shao's cross-validation method for linear models with unequal variances.
- To develop and evaluate novel re-sampling methods for genomic data with heterogeneous variances.
- To provide a validated approach for predictive model development in clinical settings.
Main Methods:
- Extension of Shao's cross-validation for linear models with unequal variances.
- Development of two novel re-sampling methods to address variance heterogeneity.
- Simulation studies to assess the performance of proposed methods with finite samples.
Main Results:
- The proposed methods effectively account for variance heterogeneity in linear models.
- Simulations demonstrated the finite sample performance of the new re-sampling techniques.
- The methods were illustrated using a breast cancer research example.
Conclusions:
- The extended method provides a robust approach for predictive model validation with genomic data.
- The proposed re-sampling methods enhance the reliability of predictive models in the presence of unequal variances.
- This work supports the use of validated predictive models in clinical development, particularly in oncology.